Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?

Overview of attention for article published in European Urology Focus , February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 24 X users

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 30 X posts from 24 X users, with an upper bound of 42,862 followers.

TL;DR or no access? ➡️ “[…] we are unable to recommend LI-ESWT as a standard treatment option for men who are PDE-5i nonresponders. Patients should only be offered LI-ESWT in an investigational setting or as off-label use with a thorough understanding of …

RT @EurUrolFocus: Throwback Thursday: Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatmen…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.